Lifeward Ltd Revenue per Employee (LFWD), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Lifeward ltd   (NASDAQ: LFWD)
 

Lifeward Ltd 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 15.71% in the second quarter 2026, year on year to cumulative value of $22 million, Lifeward Ltd 's revenue per employee grew on a trailing twelve months basis to $ 269,407. The productivity of Lifeward Ltd 's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 346 other companies have achieved higher revenue per employee. While Lifeward Ltd 's total ranking has deteriorated compared to the previous quarter from 2501 to 2689. Lifeward Ltd has 81 employees.


What is Sales per Employee Ratio?







LFWD Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 15.71 % -22.07 % -32.66 % 1.09 % -14.66 %
Sales per Employee (TTM) $ 269,407 258,309 272,025 302,444 301,617
LFWD's Total Ranking # 2689 # 2501 # 2284 # 1918 # 2017
Seq. Revenue Change 68.82 % -22.79 % -17.98 % 8.23 % 13.71 %


Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 111
Healthcare Sector # 347
Overall Market # 2689

Revenue per Employee Statistics
High Average Low
$ 316,827 $ 118,170 $ 50,025
(Dec 31 2024)   (Mar 31 2020)



Financial Statements
Lifeward Ltd 's Revenue MRQ $ 7 Millions Visit LFWD's Income Statement
Lifeward Ltd 's Revenues TTM $ 22 Millions Visit LFWD's aggregate revenue growth
What are LFWD's Sales? Visit LFWD's Sales by Segment


  News about Lifeward ltd Revenue per employee

Lifeward Ltd. Forecasts Strong 2025 Amid Impressive Growth and Strategic Capital Expansion,

Lifeward Ltd. (Nasdaq: LFWD), a key player in the healthcare sector focused on rehabilitation and recovery solutions, recently issued a year-end open letter to shareholders detailing its operational and commercial priorities for 2025. The letter provides insights into the company s recent performance, financial health, and strategic direction, signaling a robust outlook for the upcoming year. Optimistic Financial PositionIn the face of challenges within the healthcare sector, Lifeward is optimistic about its financial stability. Recent financing initiatives have bolstered the company’s capital base, allowing it to confidently state that it possesses sufficient cash flow to pursue its strategic goals. Significantly, Lifeward Ltd. achieved a remarkable revenue per employee figure of $362,360 over the trailing twelve months, positioning itself as a leader among its peers within the healthcare industry. This achievement translates to a revenue increase of 39.18% in the third quarter of 2024 compared to the same period the previous year, culminating in a cumulative revenue of $18 million. With a dedicated workforce of 50 employees, Lifeward s productivity metrics remain impressive, demonstrating an above-average productivity level essential for sustained growth. The company s ability to generate revenue efficiently is a key pillar of its operational integrity and competitive advantage.




Other Ratios
Lifeward Ltd 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
LFWD's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for LFWD's Competitors
Revenue per Employee for LFWD's Suppliers
Revenue per Employee for LFWD's Customers

You may also want to know
LFWD's Sales Growth Rates LFWD's Pe Price to earnings ratio LFWD's Receivables Turnover Ratio LFWD's Stock Quote
LFWD's Net Income Growth Rates LFWD's Ps Price to Sales ratio LFWD's Sales per Employee LFWD's Asset Turnover Ratio
LFWD's Net Margin LFWD's Pb Price to Book ratio LFWD's Financial Strength Ratios LFWD's Dividend Payout Ratio
Date modified: 2026-08-31T02:10:54+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Pelthos Therapeutics Inc   470,695.65 $ 43.304  Million 92 
Inogen Inc   470,523.24 $ 354.304  Million 753 
Regenxbio Inc   470,301.89 $ 174.482  Million 371 
4d Molecular Therapeutics Inc   469,428.57 $ 92.008  Million 196 
Stryker Corp  461,375.00 $ 25,837.000  Million 56,000 
Atara Biotherapeutics Inc   460,857.14 $ 6.452  Million 14 
Glaukos Corp  457,066.73 $ 500.031  Million 1,094 
Treace Medical Concepts Inc   456,237.78 $ 205.307  Million 450 
Medpace Holdings Inc   448,756.13 $ 2,782.288  Million 6,200 
Haemonetics Corporation  447,145.88 $ 1,351.722  Million 3,023 
Nakamoto Inc   445,571.28 $ 28.962  Million 65 
Livanova Plc  445,488.48 $ 1,470.112  Million 3,300 
Rockwell Medical inc   444,757.96 $ 69.827  Million 157 
Trisalus Life Sciences Inc   442,931.37 $ 45.179  Million 102 
Kymera Therapeutics Inc   441,176.47 $ 105.000  Million 238 
Natera Inc   440,892.02 $ 2,707.077  Million 6,140 
Electrocore Inc   440,084.34 $ 36.527  Million 83 
Mimedx Group Inc   438,225.25 $ 354.086  Million 808 
Elutia Inc   436,653.85 $ 11.353  Million 26 
Novocure Limited  435,634.27 $ 699.193  Million 1,605 
Omniab Inc   432,101.12 $ 38.457  Million 89 
Atricure Inc   420,553.33 $ 567.747  Million 1,350 
Lifemd Inc   419,956.96 $ 163.363  Million 389 
Orthopediatrics Corp  417,405.32 $ 251.278  Million 602 
3m Company  416,198.35 $ 25,180.000  Million 60,500 
Solventum Corporation  415,500.00 $ 8,310.000  Million 20,000 
Teva Pharmaceutical Industries Limited  415,463.92 $ 14,105.000  Million 33,950 
Airsculpt Technologies Inc   415,217.63 $ 150.724  Million 363 
Tandem Diabetes Care Inc   414,920.80 $ 1,037.302  Million 2,500 
Idexx Laboratories Inc  413,981.09 $ 4,553.792  Million 11,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.